215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
How do you stop a Covid surge? Why are clinical trials so white? And what are the limits of HIPAA? Our colleague Eric Boodman joins us to discuss whether an oft-cited federal law can shield reproducti...
30 Kesä 202234min
214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict
Just how powerful is the FDA? Is Merck about to spend $40 billion? And what's a "Puff Bar"? STAT Washington correspondent Nicholas Florko joins us to discuss the FDA's decision to ban the sale of Juul...
23 Kesä 202227min
213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback
Will biotech stocks ever recover? How well do Covid-19 vaccines work for kids? And can anything stop the amyloid hypothesis? Longtime biotech investor Les Funtleyder joins us to explain why the recent...
16 Kesä 202235min
212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
When is data "practice-changing"? How many Covid-19 vaccines do we need? And what does it mean when the FDA asks for more time? With the world's largest cancer conference just concluded, we explain th...
9 Kesä 202235min
211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
Will gene therapy ever live up to expectations? Can anyone break up the genomics monopoly? And is innovation actually bad for biotech? This week, health care strategist Jared Holz of Oppenheimer joins...
2 Kesä 202233min
210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
ovid vaccines for the youngest kids are up for review, but which jab — Moderna or Pfizer — will parents choose? What’s on tap for ASCO, the biggest cancer research conference of the year? And a biotec...
26 Touko 202234min
Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
What happens when the White House runs out of Covid-19 money? Why are kids suddenly getting mysterious infections? And who's going to hire Martin Shkreli? First, STAT's Helen Branswell joins us to exp...
19 Touko 202233min
Episode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise
Is the next Covid surge upon us? How do you make $350,000 a day in biotech? And when did Seagen find out about its CEO's arrest? First, we discuss the latest alarming trends in the Covid-19 pandemic a...
12 Touko 202232min
